
UK’s competition watchdog stated that ticket reseller Viagogo’s US$4.05 billion completed deal for StubHub, the ticketing unit of US e-commerce company eBay, will reduce competition, reported Reuters.
The Competition and Markets Authority (CMA) stated that its in-depth investigation provisionally found that the merger could lead to increases in fees for customers and could result in a lower quality of service and reduced innovation in the sector.
The merger could lead to increased fees for customers, including individuals, who resell or buy secondary tickets to live events, the CMA stated its investigation found.
It could also result in a lower quality of service and reduce competition and innovation in the sector, the CMA stated.
“Whilst we disagree with the provisional conclusion that the deal would reduce competition, we look forward to working with the CMA to deliver a comprehensive solution which addresses their concerns,” a Viagogo spokesperson said.
The CMA, which started its probe in April, stated it was mindful of the significant impact of the coronavirus crisis on the live events industry.
“However, the evidence is that Viagogo and StubHub would remain important competitors for the foreseeable future without the merger,” the CMA stated.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas